3-(5-甲酰基-2-呋喃基)苯甲酸 | 304884-54-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(5-甲酰基-2-呋喃基)苯甲酸
• 中文别名: 3-(5-甲酰-2-呋喃)苯甲酸；3-(5-甲酰呋喃-2-基)苯甲酸
• 英文名称: 3-(5-formylfuran-2-yl)benzoic acid
• 英文别名: 3-(5-Formyl-2-furyl)benzoic acid
• CAS: 304884-54-6
• 化学式: C₁₂H₈O₄
• mdl: MFCD00454916
• 分子量: 216.193
• InChiKey: WOAXPFPTVKBPAC-UHFFFAOYSA-N

物化性质

• 熔点：
  264-266 °C(Solv: isopropanol (67-63-0))
• 沸点：
  464.8±40.0 °C(Predicted)
• 密度：
  1.336±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.5
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(5-甲酰基-2-呋喃基)苯甲酸 在 硫酸 作用下， 以 乙醇 为溶剂， 反应 8.0h， 生成 methyl 3-(5-((2-(benzothiazol-2-yl)hydrazono)methyl)furan-2-yl)benzoate
  参考文献：
  名称：

  Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-X_L

  摘要：

  Developing potent molecules that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery. We describe the hit-to-lead development of selective Bcl-X-L inhibitors originating from a high-throughput screening campaign. Small structural changes to the hit compound increased binding affinity more than 300-fold (to IC50 < 20 nM). This molecular series exhibits drug-like characteristics, low molecular weights (M-w < 450) and unprecedented selectivity for Bcl-X-L. Surface plasmon resonance experiments afford strong evidence of binding affinity within the hydrophobic groove of Bcl-X-L. Biological experiments using engineered Mcl-1 deficient mouse embryonic fibroblasts (MEFs, reliant only on Bcl-X-L, for survival) and Bax/Bak deficient MEFs (insensitive to selective activation of Bcl-2-driven apoptosis) support a mechanism-based induction of apoptosis. This manuscript describes the first series of selective small-molecule inhibitors of Bcl-X-L and provides promising leads for the development of efficacious therapeutics against solid tumors and chemoresistant cancer cell lines.

  DOI：

  10.1021/jm400556w
• 作为产物：
  描述：

  糠醛 、 间氨基苯甲酸 生成 3-(5-甲酰基-2-呋喃基)苯甲酸
  参考文献：
  名称：

  Heterocyclic compounds as pharmaceutically active compounds

  摘要：

  本发明涉及通式(I)的呋嗪并吡嗪衍生物，其中：R′代表—NR1R2或—OR9；R″代表—NR5—NR3R4，—NR5—ORb，—O—NR3R4；在公式(I)中，R1至R9独立地代表多种不同的取代基，包括烷基、芳基、芳基烷基、烷基芳基、杂环芳基基团和单官能团。

  公开号：

  US20050143382A1

文献信息

• Synthesis and Biological Evaluation of Halogenated 2-Arylimino-3-arythiazolidine- 4-ones Containing Benzoic Acid Fragments as Antibacterial Agents
  作者：Jie Zhang、Likang Zheng、Huayong Liu、Dan Zhao、Di Qu、Shiqing Han

  DOI：10.2174/15701808113109990031

  日期：2013.10.1

  A series of halogenated 2-arylimino-3-ary-thiazolidine-4-ones containing (5-furan-2-yl)-benzoic acid or (5-thiophene-2-yl)-benzoic acid fragments were synthesized, and evaluated in vitro for their antibacterial activity, antibiofilm activity, erythrocyte hemolysis and cytotoxicity. Compounds (7c, 7f, 7i, 7n and 7p) exhibited excellent potency in inhibiting the growth of Staphylococcus epidermidis ATCC35984 (minimal inhibitory concentration (MIC): 0.8 μg/mL). The five compounds also presented promising antibiofilm activity against S. epidermidis ATCC35984 and none of them showed obvious hemolytic activity and cytotoxicity. Further antibacterial effects of the selected five compounds (7c, 7f, 7i, 7n and 7p) against clinical isolates (methicillin-resistant Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus) were investigated in comparison with methicillin and ampicillin.7p showed the most potent antibacterial activities among the synthesized compounds.

  合成了包含(5-呋喃-2-基)苯甲酸或(5-噻吩-2-基)苯甲酸片段的一系列卤代2-芳基亚胺-3-芳基-噻唑烷-4-酮，并在体外评估了它们的抗菌活性、抗生物膜活性、红细胞溶血和细胞毒性。化合物(7c、7f、7i、7n和7p)表现出优异的抑制表皮葡萄球菌ATCC35984生长的功效（最小抑制浓度(MIC)：0.8 μg/mL）。这五种化合物还显示出对表皮葡萄球菌ATCC35984有前景的抗生物膜活性，并且均未表现出明显的溶血活性和细胞毒性。进一步研究了选定的五种化合物(7c、7f、7i、7n和7p)对临床分离株（耐甲氧西林表皮葡萄球菌和耐甲氧西林金黄色葡萄球菌）的抗菌效果，并与甲氧西林和氨苄西林进行了比较。7p在合成的化合物中显示出最强的抗菌活性。
• Synthesis and biological evaluation of 2-arylimino-3-pyridin-thiazolineone derivatives as antibacterial agents
  作者：Ming-Guang Cai、Yang Wu、Jun Chang

  DOI：10.1016/j.bmcl.2016.03.089

  日期：2016.5

  With an intention to find more potent antibacterial agents, four halogen disubstituted thiazolineone derivatives (2a-d), five halogen monosubstituted thiazolineone derivatives (2e-i), and eleven 2-arylimino-3-pyridin-thiazolineone derivatives (2j-t) were synthesized and screened for their antibacterial activity, bactericidal activity, cytotoxicity, and erythrocyte hemolysis. Most of the synthesized

  为了寻找更有效的抗菌剂，分别开发了四种卤素二取代的噻唑啉酮衍生物（2a-d），五个卤素单取代的噻唑啉酮衍生物（2e-i）和十一种2-芳基氨基-3-吡啶-噻唑啉酮衍生物（2j-t）。合成并筛选了它们的抗菌活性，杀菌活性，细胞毒性和红细胞溶血作用。大多数合成衍生物在抑制表皮葡萄球菌和MRSA的生长中显示出抗菌活性，并且在Vero细胞的细胞毒性研究和健康人红细胞的溶血活性试验中显示出安全性。2-Arylimino-3-pyridin-thiazolineone衍生物不仅改善了clog P，而且在抑制表皮葡萄球菌和MRSA的生长中显示出强大的抗菌活性。特别是几种化合物（2f，2i，
• Oxadiazolopyrazine derivatives as pharmaceutically active compounds
  申请人：4SC AG

  公开号：EP1529531A1

  公开（公告）日：2005-05-11

  The present invention relates to furazanopyrazine derivatives of the general formula (I): wherein: R' represents -NR1R2 or -OR9 R" represents -NR5-NR3R4, -NR5-ORb, -O-NR3R4; wherein R1 to R9 in formula (1) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties.

  本发明涉及一般式(I)的呋嗪吡唑衍生物： 其中： R'代表-NR1R2或-OR9 R"代表-NR5-NR3R4，-NR5-ORb，-O-NR3R4； 其中式(1)中的R1至R9分别独立地代表各种不同取代基，包括烷基、芳基、芳基烷基、烷基芳基、杂环芳基和单官能团。
• Functionally substituted isoxazoles and isothiazoles: Synthesis, palladium(II) complexes and their catalytic activity
  作者：N. A. Bumagin、V. M. Zelenkovskii、A. V. Kletskov、S. K. Petkevich、E. A. Dikusar、V. I. Potkin

  DOI：10.1134/s1070363216010138

  日期：2016.1

  , whose molecules contain azomethine, amino, carboxyl, and ester moieties in various combinations in the aromatic ring in the position 3 of heterocycle, were synthesized. Synthesis of complexes of Pd(II) with carboxyl derivative of 1,2-azoles was performed. They show high catalytic activity in the Suzuki reaction in aqueous media.

  合成了官能取代的5-（对甲苯基）异恶唑和4,5-二氯异噻唑，其分子在杂环的3位芳香环中以各种组合包含偶氮甲碱，氨基，羧基和酯部分。进行了Pd（II）与1,2-唑类羧基衍生物的配合物的合成。它们在水性介质中的Suzuki反应中显示出高催化活性。
• Design, Synthesis, and Interaction Study of Quinazoline-2(1<i>H</i>)-thione Derivatives as Novel Potential Bcl-x_L Inhibitors
  作者：Yu Feng、Xiao Ding、Tao Chen、Lili Chen、Fang Liu、Xu Jia、Xiaomin Luo、Xu Shen、Kaixian Chen、Hualiang Jiang、Hui Wang、Hong Liu、Dongxiang Liu

  DOI：10.1021/jm901004c

  日期：2010.5.13

  Development of inhibitors to antagonize the activities of antiapoptotic Bcl-2 family proteins is of particular interest in cancer chemotherapy. We discovered a quinazoline-2(1H)-thione derivative (DCBL55) as a new Bcl-xL, Bcl-2, and Mcl-1 inhibitor by virtual database screening. We systematically modified the structure of compound 1 by chemical synthesis. The interactions of the compounds with Bcl-xL

  拮抗抗凋亡的Bcl-2家族蛋白活性的抑制剂的开发在癌症化学疗法中尤为重要。通过虚拟数据库筛选，我们发现了一种喹唑啉-2（1 H）-硫酮衍生物（DCBL55）作为新的Bcl-x L，Bcl-2和Mcl-1抑制剂。我们通过化学合成系统地修饰了化合物1的结构。通过分子模拟模拟预测了化合物与Bcl-x L的相互作用，并通过结构-活性关系分析和蛋白质突变研究证实了这一点。Bcl-x L疏水槽的三个位置发现被称为P2，P4和P5的P2，P4和P5有助于配体相互作用。尽管该化合物诱导线粒体电位降低，半胱天冬酶激活和ROS产生，但细胞毒性和线粒体外膜的超微结构变化表明该化合物可能靶向Bcl-2家族以外的其他蛋白质。总之，本研究提供了新的先导化合物和重要的结构信息，以进一步开发抗凋亡Bcl-2家族蛋白的更强效和特异性抑制剂。